Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 2/20 | 0.47 |
| ▸ | GSK3B | P49841 | 9/20 | 0.46 |
| ▸ | STK10 | O94804 | 7/20 | 0.46 |
| ▸ | SLK | Q9H2G2 | 7/20 | 0.46 |
| ▸ | GSK3A | P49840 | 3/20 | 0.44 |
| ▸ | TGM2 | P21980 | 3/20 | 0.41 |
| ▸ | RET | P07949 | 1/20 | 0.41 |
| ▸ | GRK5 | P34947 | 1/20 | 0.41 |
| ▸ | TYRO3 | Q06418 | 1/20 | 0.41 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.41 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.40 |
| ▸ | WEE1 | P30291 | 1/20 | 0.40 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.39 |
| ▸ | NSD2 | O96028 | 1/20 | 0.39 |
| ▸ | BCHE | P06276 | 1/20 | 0.39 |
| ▸ | DAO | P14920 | 1/20 | 0.39 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.38 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.38 |
| ▸ | BRDT | Q58F21 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30445783 | 0.86 | CES1 (0.55) | CES1GSK3BSTK10SLKGSK3A | |
| SCHEMBL2834495 | 0.80 | CES1 (0.50) | CES1GSK3BSTK10SLKGSK3A | |
| SCHEMBL12424909 | 0.74 | CES1 (0.52) | CES1GSK3BSTK10SLKGSK3A | |
| SCHEMBL30999976 | 0.73 | GSK3B (0.59) | GSK3BSTK10SLKGSK3ACHEK1 | |
| Zinc Ion SCHEMBL29019629 | 0.72 | CES1 (0.39) | CES1GSK3BSTK10SLKGSK3A | |
| SCHEMBL2834835 | 0.70 | PRKCB (0.74) | GSK3B | |
| SCHEMBL187764 | 0.69 | PTGS2 (0.61) | GSK3B | |
| SCHEMBL261439 | 0.69 | GSK3B (0.52) | CES1GSK3BSTK10SLKTGM2 | |
| SCHEMBL2838987 | 0.69 | PPOX (0.52) | CES1GSK3BSTK10SLKGSK3A | |
| SCHEMBL12425026 | 0.67 | PBRM1 (0.45) | CES1GSK3BSTK10SLKTGM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100152044-A1 | Plant growth regulation | BAYER CROPSCIENCE GMBH (DE) | 2010-06-17 | — | — | US | disclosed |
| EP-1746886-A1 | PLANT GROWTH REGULATION | Bayer CropScience GmbH (DE) | 2007-01-31 | — | — | EP | disclosed |
| WO-2005107465-A1 | PLANT GROWTH REGULATION | BAYER CROPSCIENCE GMBH (DE) | 2005-11-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100152044-A1 | Plant growth regulation | ING2, GHITM, MYB | CES1 3454/4885GSK3B 522/4885STK10 887/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.